Orly Dorot, Ph.D.

Senior Scientist, Assay Development

Orly joined DeepCure in 2022 as a Senior Scientist – Assay Development. Orly, PhD. is a molecular biologist and an expert in early drug discovery and screening and in using automation instrumentation for high content analysis (HCA) and bioassays. Before joining DeepCure, Orly spent five years as a senior scientist and project leader in the High Throughput Screening (HTS) unit at the BLAVATNIK CENTER for Drug Discovery, where she worked on neurodegenerative disorders, metabolic disorders, rare diseases, and oncology projects. Orly received her PhD. from Tel-Aviv University, Israel, where she completed her doctoral and post-doctoral research under the supervision of Prof. Mia Horowitz and Prof. Danny Segal.